ProjectA prospective, open-label, multicenter, randomized phase III trial to compare the efficacy and safety of a…

Basic data

Title:

A prospective, open-label, multicenter, randomized phase III trial to compare the efficacy and safety of a combined regimen of obinutuzumab and GDC-0199 (ABT-199) versus obinutuzumab and chlorambucil in previously untreated patients with CLL and coexisting medical conditions

Duration:

01/07/2015 to 30/06/2018

Abstract / short description:

A PROSPECTIVE, OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE III TRIAL TO COMPARE THE EFFICACY AND SAFETY OF A COMBINED REGIMEN OF OBINUTUZUMAB AND GDC-0199 (ABT-199) VERSUS OBINUTUZUMAB AND CHLORAMBUCIL IN PREVIOUSLY UNTREATED PATIENTS WITH CLL AND COEXISTING MEDICAL CONDITIONS

Keywords:

clinical trial

klinische Studie

Involved staff

Managers

Nikolaou, Konstantin

Faculty of Medicine
University of Tübingen

Local organizational units

Department of Diagnostic and Interventional Radiology

Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Roche Pharma AG

Grenzach-Wyhlen, Baden-Württemberg, Germany